Share

December 2022; 12 (6) Research Article

Telemedicine Utilization Among Patients With Multiple Sclerosis in the US Veterans Health Administration, 2010–2020

Hoda S. Abdel Magid, Shan Jin, William J. Culpepper, Lorene M. Nelson, Mitchell Wallin
First published October 12, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000200078
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
49

Share

Article Information

vol. 12 no. 6 e133-e142
DOI: 
https://doi.org/10.1212/CPJ.0000000000200078
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received February 28, 2022
  • Accepted August 8, 2022
  • First Published October 12, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Hoda S. Abdel Magid, MHS, PhD,
    2. Shan Jin, PhD,
    3. William J. Culpepper, PhD,
    4. Lorene M. Nelson, PhD, MS and
    5. Mitchell Wallin, MD, MPH
  1. Hoda S. Abdel Magid, MHS, PhD,
    2. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Shan Jin, PhD,
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. VA Employee Income

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. William J. Culpepper, PhD,
    4. Scientific Advisory Boards:

    1. National MS Prevalence Work Group, National MS Society

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Lorene M. Nelson, PhD, MS and
    5. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. Neuroepidemiology, Associate Editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. Neuroepidemiology: From Principles to Practice (Oxford University Press, 2004)

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Centers for Disease Control, ATSDR, grant 1R01TS000249-01, Principal Investigator, 2016-2019(2) National Institutes of Health (NINDS), grant 4U01NS038455-15, Co-Investigator, 2013-2022(3) Centers for Disease Control, ATSDR, Interagency agreement, ALS Capture-Recapture Analysis, Principal Investigator, 2015-2019(4) National Institutes of Health, SPO #131896, Site Co-Investigator, 2018-2022(5) NIH/NCATS, grant 4UL1TR00185-01, Co-Investigator, 2013-2022

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National Multiple Sclerosis Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Mitchell Wallin, MD, MPH
    6. Scientific Advisory Boards:

    1. I have served on the North American Registry for Care and Research on Multiple Sclerosis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Funding for travel, room and board for the Consortium of MS Centers and the PVA Summit conferences in 2022

    Editorial Boards:

    1. Associate Editor, Encyclopedia of the Neurological Sciences Neuroepidemiology SectionEditorial Board member, Neuroscience Journal

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant to the Global Burden of Disease Network (non-profit)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. VA Merit Review, RX002682-01, and BX2625, co-I

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National MS Society, HC-1508-05693

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. VA Palo Alto Healthcare System (HSAM), US Department of Veterans Affairs, Palo Alto, CA; Department of Epidemiology and Population Health (HSAM, LMN), Stanford University School of Medicine, CA; Center for Population Health Sciences (HSAM, LMN), Stanford University School of Medicine, CA; Health Economics Research Center (HSAM), Veterans Affairs Palo Alto Health Care System, CA; VA Multiple Sclerosis Center of Excellence-East (SJ, WJC, MW), Baltimore, MD; University of Maryland School of Medicine (WJC, MW), Neurology Department, Baltimore, MD; and Epidemiology Program (WJC), Health Outcomes of Military Exposures, Veteran Health Administration, Washington, DC.
  1. Correspondence
    Dr. Abdel Magid hmagid{at}stanford.edu
View Full Text

Article usage

Article usage: October 2022 to August 2023

AbstractFullPdfSource
Oct 202225708Highwire
Nov 202223305Highwire
Dec 20223622914Highwire
Jan 202324357Highwire
Feb 202315055Highwire
Mar 202317532Highwire
Apr 202314001Highwire
May 202316011Highwire
Jun 20236121Highwire
Jul 20232822Highwire
Aug 20233363Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me